Shares of Cardiovascular Systems Inc. (NASDAQ:CSII) traded up 6.9% during mid-day trading on Friday . The stock traded as high as $20.20 and last traded at $19.77, with a volume of 239,854 shares changing hands. The stock had previously closed at $18.50.

Several analysts recently issued reports on the company. Needham & Company LLC restated a “buy” rating and issued a $23.00 price target (up from $20.00) on shares of Cardiovascular Systems in a research note on Wednesday, June 29th. Zacks Investment Research upgraded Cardiovascular Systems from a “hold” rating to a “buy” rating and set a $21.00 price target for the company in a research note on Monday. Finally, Leerink Swann restated a “market perform” rating and issued a $15.00 price target (up from $13.00) on shares of Cardiovascular Systems in a research note on Saturday, May 7th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and six have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $20.57.

The company’s market capitalization is $636.80 million. The firm’s 50 day moving average price is $17.45 and its 200-day moving average price is $13.23.

Cardiovascular Systems (NASDAQ:CSII) last issued its quarterly earnings results on Wednesday, May 4th. The medical device company reported ($0.31) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.54) by $0.23. The business had revenue of $44.50 million for the quarter, compared to analysts’ expectations of $42.13 million. The business’s revenue was down 5.3% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.34) earnings per share. Analysts anticipate that Cardiovascular Systems Inc. will post ($1.75) earnings per share for the current year.

A hedge fund recently raised its stake in Cardiovascular Systems stock. Brown Advisory Inc. raised its position in shares of Cardiovascular Systems Inc. (NASDAQ:CSII) by 2.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 342,446 shares of the medical device company’s stock after buying an additional 7,010 shares during the period. Brown Advisory Inc. owned 1.05% of Cardiovascular Systems worth $5,178,000 as of its most recent SEC filing.

Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary arterial diseases. It has developed an orbital atherectomy technology for peripheral and coronary commercial applications. Its peripheral arterial disease systems are catheter-based platforms that treat plaque types in leg arteries both above and below the knee.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.